These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36633291)

  • 1. Microfluidic Fabrication of Silica Microspheres Infused with Positron Emission Tomography Imaging Agents.
    Larsen LI; López GP; Selwyn R; Carroll NJ
    ACS Appl Bio Mater; 2023 Feb; 6(2):712-721. PubMed ID: 36633291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
    Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
    Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors.
    Kucuk ON; Soydal C; Lacin S; Ozkan E; Bilgic S
    World J Surg Oncol; 2011 Aug; 9():86. PubMed ID: 21819613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography.
    Campbell JM; Wong CO; Muzik O; Marples B; Joiner M; Burmeister J
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):313-20. PubMed ID: 19362251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High quality imaging and dosimetry for yttrium-90 (
    Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging.
    Walrand S; Hesse M; Chiesa C; Lhommel R; Jamar F
    J Nucl Med; 2014 Jan; 55(1):135-40. PubMed ID: 24296766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of imaging
    Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
    Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
    Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of post-treatment PET-based dosimetry software for hepatic radioembolization of Yttrium-90 microspheres.
    Maughan NM; Garcia-Ramirez J; Arpidone M; Swallen A; Laforest R; Goddu SM; Parikh PJ; Zoberi JE
    Med Phys; 2019 May; 46(5):2394-2402. PubMed ID: 30742714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron detection in silica monoliths for miniaturised quality control of PET radiotracers.
    Tarn MD; Maneuski D; Alexander R; Brown NJ; O'Shea V; Pimlott SL; Pamme N; Archibald SJ
    Chem Commun (Camb); 2016 Jun; 52(45):7221-4. PubMed ID: 27029282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of radiodetection systems towards miniaturised quality control of PET and SPECT radiopharmaceuticals.
    Taggart MP; Tarn MD; Esfahani MM; Schofield DM; Brown NJ; Archibald SJ; Deakin T; Pamme N; Thompson LF
    Lab Chip; 2016 Apr; 16(9):1605-16. PubMed ID: 27044712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET.
    Lin M; Shon IH; Wilson R; D'Amours SK; Schlaphoff G; Lin P
    Hepatogastroenterology; 2007; 54(75):910-2. PubMed ID: 17591090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimisation of reconstruction, volumetry and dosimetry for
    Bernardini M; Thevenet H; Berthold C; Desbrée A; Smadja C; Desiré C; Bianciardi M; Ghazzar N
    Phys Med; 2017 Jul; 39():147-155. PubMed ID: 28687192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can pretreatment hepatic artery perfusion scintigraphy in patients with liver malignancies predict the treatment response of the selective internal radiation therapy with 90Y resin microspheres?
    Guney IB; Balli HT; Kucuker KA; Unal I; Kibar M
    Diagn Interv Radiol; 2022 Mar; 28(2):156-165. PubMed ID: 35548900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron-emitting resin microspheres as surrogates of 90Y SIR-Spheres: a radiolabeling and stability study.
    Avila-Rodriguez MA; Selwyn RG; Hampel JA; Thomadsen BR; Dejesus OT; Converse AK; Nickles RJ
    Nucl Med Biol; 2007 Jul; 34(5):585-90. PubMed ID: 17591559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
    Martí-Climent JM; Prieto E; Elosúa C; Rodríguez-Fraile M; Domínguez-Prado I; Vigil C; García-Velloso MJ; Arbizu J; Peñuelas I; Richter JA
    Med Phys; 2014 Sep; 41(9):092503. PubMed ID: 25186412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: a radiolabeling and PET validation study.
    Selwyn RG; Avila-Rodriguez MA; Converse AK; Hampel JA; Jaskowiak CJ; McDermott JC; Warner TF; Nickles RJ; Thomadsen BR
    Phys Med Biol; 2007 Dec; 52(24):7397-408. PubMed ID: 18065846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology.
    Tehranipour N; AL-Nahhas A; Canelo R; Stamp G; Woo K; Tait P; Gishen P
    Clin Nucl Med; 2007 May; 32(5):371-4. PubMed ID: 17452865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of glass microspheres comprising 90Y and (177)Lu for treating of hepatic tumors with SPECT imaging capabilities.
    Poorbaygi H; Reza Aghamiri SM; Sheibani S; Kamali-Asl A; Mohagheghpoor E
    Appl Radiat Isot; 2011 Oct; 69(10):1407-14. PubMed ID: 21723135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres.
    Ebbers SC; Kunnen B; van Nierop BJ; Bemelmans JLM; Krijger GC; Lam MGEH; Braat AJAT
    Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1378-1383. PubMed ID: 32435831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.